A Randomized Controlled Trial of a Paclitaxel-Eluting Stent Versus a Similar Bare-Metal Stent in Saphenous Vein Graft Lesions. The SOS (Stenting Of Saphenous Vein Grafts) Trial

Journal of the American College of Cardiology

Volumn 53, Issue 11, 2009, Pages 919-928

  Brilakis, Emmanouil S ^a,b   Lichtenwalter, Christopher ^a,b   de Lemos, James A ^a,b   Roesle, Michele ^a   Obel, Owen ^a,b   Haagen, Donald ^a   Saeed, Bilal ^c   Gadiparthi, Chiranjeevi ^a,b   Bissett, Joseph K ^d   Sachdeva, Rajesh ^d   Voudris, Vassilios V ^e   Karyofillis, Panagiotis ^e   Kar, Biswajit ^f   Rossen, James ^g   Fasseas, Panayotis ^h   Berger, Peter ⁱ   Banerjee, Subhash ^a,b  

^a Veterans Affairs North Texas Health Care System   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e ONASSIS CARDIAC SURGERY CENTER   (Greece)

^f MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h Wheaton Franciscan Healthcare   (United States)

ⁱ GEISINGER MEDICAL CENTER   (United States)

Author keywords

bare metal stents; coronary artery bypass graft surgery; drug eluting stents; outcomes; percutaneous coronary intervention; saphenous vein grafts

Indexed keywords

'TAXUS'; ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PACLITAXEL; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ANTICOAGULATION; ARTERY DISSECTION; ARTICLE; BARE METAL STENT; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CREATINE KINASE BLOOD LEVEL; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEMATOMA; HUMAN; IN-STENT RESTENOSIS; ISCHEMIA; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHESIS FAILURE; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SAPHENOUS VEIN GRAFT; SINGLE BLIND PROCEDURE; STABLE ANGINA PECTORIS; STENT THROMBOSIS; TREATMENT DURATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; VEIN GRAFT DISEASE;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; SAPHENOUS VEIN; STENTS; TICLOPIDINE;

EID: 61549089702     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.11.029     Document Type: Article

References (25)

1. Brilakis E.S., Saeed B., and Banerjee S. Use of drug-eluting stents in saphenous vein aortocoronary bypass graft lesions: a critical appraisal. J Interv Cardiol 21 (2008) 151-157
2. Vermeersch P., Agostoni P., Verheye S., et al. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC trial. J Am Coll Cardiol 48 (2006) 2423-2431
3. Vermeersch P., Agostoni P., Verheye S., et al. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial. J Am Coll Cardiol 50 (2007) 261-267
4. Coolong A., Baim D.S., Kuntz R.E., et al. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation 117 (2008) 790-797
5. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 47 (2006) e1-e121
6. Antman E., Bassand J.-P., Klein W., et al. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: The Joint European Society of Cardiology/American College of Cardiology Committee. J Am Coll Cardiol 36 (2000) 959-969
7. Cutlip D.E., Windecker S., Mehran R., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
8. Mauri L., Hsieh W.-h., Massaro J.M., Ho K.K.L., D'Agostino R., and Cutlip D.E. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356 (2007) 1020-1029
9. Ge L., Iakovou I., Sangiorgi G.M., et al. Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome. J Am Coll Cardiol 45 (2005) 989-994
10. Lee M.S., Shah A.P., Aragon J., et al. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. Catheter Cardiovasc Interv 66 (2005) 507-511
11. Hoffmann R., Pohl T., Koster R., Blindt R., Boeckstegers P., and Heitzer T. Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study. Heart 93 (2007) 331-334
12. Minutello R.M., Bhagan S., Sharma A., et al. Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease. J Interv Cardiol 20 (2007) 458-465
13. Kaplan S., Barlis P., Kiris A., Dimopoulos K., Celik S., and Di Mario C. Immediate procedural and long-term clinical outcomes following drug-eluting stent implantation to ostial saphenous vein graft lesions. Acute Card Care 10 (2008) 88-92
14. Brodie B.R., Stuckey T., Downey W., et al. Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group. J Am Coll Cardiol Intv 1 (2008) 405-414
15. Chu W.W., Rha S.W., Kuchulakanti P.K., et al. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention. Am J Cardiol 97 (2006) 34-37
16. Ellis S.G., Kandzari D., Kereiakes D.J., et al. Utility of sirolimus-eluting cyphertrade mark stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study. J Invasive Cardiol 19 (2007) 404-409
17. Wohrle J., Nusser T., Kestler H.A., Kochs M., and Hombach V. Comparison of the slow-release polymerbased paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions. Clin Res Cardiol 96 (2007) 70-76
18. Bansal D., Muppidi R., Singla S., et al. Percutaneous intervention on the saphenous vein bypass grafts-long-term outcomes. Catheter Cardiovasc Interv 71 (2008) 58-61
19. Vignali L., Saia F., Manari A., et al. Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emilia-Romagna Registry). Am J Cardiol 101 (2008) 947-952
20. Okabe T., Lindsay J., Buch A.N., et al. Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts. Am J Cardiol 102 (2008) 530-534
21. Gioia G., Benassi A., Mohendra R., Chowdhury K., Masood I., and Matthai W. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts. Catheter Cardiovasc Interv 72 (2008) 13-20
22. Ramana R.K., Ronan A., Cohoon K., et al. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease. Catheter Cardiovasc Interv 71 (2008) 886-893
23. Applegate R.J., Sacrinty M., Kutcher M., Santos R., Gandhi S., and Little W. Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: propensity score analysis. Catheter Cardiovasc Interv 72 (2008) 7-12
24. Jeger R.V., Schneiter S., Kaiser C., et al. Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions. Cardiology 112 (2008) 49-55
25. Brilakis E.S., and Berger P.B. Should bare metal or drug-eluting stents be used during PCI of saphenous vein graft lesions: waiting for Godot?. Catheter Cardiovasc Interv 72 (2008) 815-818